- One of the fastest-growing subspecialties, and what’s driving it
- Continuing certification: Upholding our commitment to patients through lifelong learning
- 236 women hospital and health system presidents and CEOs to know | 2026
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- 22 new behavioral health study findings to know
- 37 behavioral health executive moves to know
- Aspen Dental targets fast-growing Georgia city for new practice
- Michael Dowling: Now is not the time to abandon gun safety efforts
- A new wording test on ‘Medicare for All’
- UCI Health started as 1 hospital. 50 years and 6 hospitals later, CEO charts its future
- Virtua Health names president of 2 New Jersey hospitals
- Colorado wildfires send dozens to UCHealth hospitals
- Northwell appoints chair of surgery
- How 5 health systems are avoiding a repeat of the 2023 chemo shortage
- Oswego Health expands surgery, orthopedic services New York
- The ASC tax squeeze is gaining momentum
- The private equity race regulators haven’t caught up to
- Weill Cornell taps new chair of surgery, surgeon-in-chief
- Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
- The state-by-state battle over anesthesia time caps
- What happens to ASC contracts when a payer gets absorbed
- What will make or break the future of DSO success
- Dentistry reaches inflection point with AI
- Former UPMC cardiologist drops lawsuit over CEO’s device company ties
- Dental assistant pay vs. cost of living by state
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- GI consolidation’s new era: 5 deals to know
- The GI procedure cuts in CMS’ pay proposal: 5 things to know
- ‘The economics just don’t work’: CMS’ ACCESS model draws scrutiny
- Washington restricts spit hood use in state psychiatric facilities
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- Maryland health system receives $10M gift to construct ASC
- 1-800-Dentist faces class-action lawsuit over data breach
- Staten Island hospital debuts mobile behavioral health program for youth
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Telehealth ex-CEO sentenced in Adderall fraud case: 5 things to know
- Oklahoma awards 4 behavioral health clinic contracts
- The key to patient trust in dentistry
- Good news, bad news for the dental workforce
- 7 behavioral health layoffs to know | 2026
- 200+ dentists making headlines halfway through 2026
- How students are paying for dental school
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- U of Kentucky dental dean receives top educator award
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- ACA plans set for another year of premium spikes, preliminary filings show
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Foreign drugmaker caught faking doctors’ petition to evade China’s price cut scheme
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
- Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Primary care’s AI moment
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO
- Catalent sells UK facility to Codis, expands Nanoscope partnership
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Nonprofit-private equity joint ventures worth scrutiny, PESP report says
- American Heart Association joins social network Roon for medical research collaboration
- Independent pharmacies hit Prime Therapeutics with antitrust suit over alleged price fixing
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Novartis dismisses 322 more staffers based out of US headquarters
- Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa
- FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
- Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
- Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub
- Nonprofit hospitals are embracing high-risk, high-reward investment portfolios. Is that a problem?
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Teladoc Health inks multi-year virtual care deal with National Basketball Players Association
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- New Medicaid Work Rule Means More Opportunities To Lose Coverage
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Epic plans to expand 4 executives' roles as President Sumit Rana exits the company
- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Regulatory tracker: AbbVie, Genmab's blood cancer bispecific expands label in EU
- Can A Popular Muscle Supplement Help Treat Depression?
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
Michigan healthcare freedom community forum
Aside from the state dispensing drugs under the first bill, this agenda looks remarkably like deregulation.
The devil will be in the details of bill language and changes made during passage.
Wednesday, October 2, 2024 12:30 p.m.
AGENDA
SB 542 Sen. Hertel Health; pharmaceuticals; choice of formulation, dosage, and route of administration for opioid antagonists by certain persons and governmental entities if department of health and human services distributes opioid antagonists free of charge; allow.
SB 668 Sen. Hertel Health occupations; physical therapists; prescription requirement for physical therapy treatment; eliminate, and make other modifications to the practice of physical therapy.
And any other business properly before the committee.
SB 542 Background:
Traditionally, there are two ways to get medications: some are over the counter (OTC), others require a prescription (Rx).
Michigan legislators created a third way about a year ago. For certain prescription drugs, they removed the need for a personal clinician. Instead, the state's MDHHS Medical Director writes a blanket Rx/ standing order for all pharmacies, directing them to dispense certain drugs (EMS opioid reversal drugs, for example).
Around the same time, the FDA removed the prescription requirement for Narcan. The cheapest, most common opioid reversing drug (Narcan) has been available over the counter ever since.
Michigan's response was problematic. Instead of allowing the public to go buy OTC Narcan for themselves, family, friends, or emergencies, the state racked up massive orders of Narcan to stock state police, schools, libraries, bars, and more institutions who might, one day, see a person with a drug overdose.
Predictably, massive demand raised prices and created shortages for those with real-life need.
Now, the state is doubling down.
More accurately, the state is using the legislative process to double down and increase the MDHHS role as drug distributor.
Questions we should ask:
- Why is the state expanding into the pharmacy space?
- Instead, shouldn't we make sure MDHHS is performing its core mission well?
The Senate Fiscal Agency (SFA) captures the facts of this bill.
https://legislature.mi.gov/documents/2023-2024/billanalysis/Senate/pdf/2023-SFA-0542-F.pdf
CONTENT
The bill would enact a new law to allow a person or governmental entity that was distributed an opioid antagonist by the Department of Health and Human Services (DHHS) at no cost to choose the formulation, type of delivery device, method of administration, or dosage of the opioid antagonist that the person or agency received; however, the bill specifies that the ability to choose the formulation or dosage of an opioid antagonist would not apply if that formulation or dosage choice jeopardized the DHHS's receipt of Federal funding.
"Opioid antagonist" would mean naloxone hydrochloride or any other similarly acting and equally safe drug approved by the United States Food and Drug Administration for the treatment of drug overdose.
BRIEF RATIONALE
The bill would give the individuals fighting the opioid crisis a choice about how best to administer opioid antagonists. According to testimony, opioids are the cause of 80% of drug deaths in Michigan and were responsible for the deaths of 3,000 Michigan residents in 2023.
Testimony also indicates that the Centers for Disease Control found that 40% of opioid overdoses occur in the presence of another individual. The ability to request a specific opioid antagonist formulation, device, dosage, or administration method could make the use of an opioid antagonist more successful in the event of an overdose, saving more lives.FISCAL IMPACT
The bill would have an indeterminate negative fiscal impact on the DHHS and no fiscal impact on local units of government. Currently, the DHHS operates a naloxone portal that provides intranasal and injectable naloxone to health organizations, community organizations, schools, bars and nightclubs, law enforcement, and other relevant agencies at no cost. The bill would expand the type of opioid antagonists available through the naloxone portal by allowing the receiving entity to choose the formulation, type of delivery device, method of administration, or dosage of the opioid antagonist. This would increase costs for the DHHS by potentially increasing the number of opioid antagonists distributed but could also increase costs through the distribution of more costly opioid antagonists. Additionally, the DHHS would face an increased administrative burden by increasing the complexity of requests.
Date Completed: 10-3-24
Each bill typically gets two hearings.
The PT bill is up again this week, along with a few more. The added bills bring new mental health mandates to hospitals, courts, and clinicians.
NAVIGATION NOTE: by scrolling up to the MI Senate - Health Policy tab in the Forum, you can find links to look up bills, committee live video feed, and hearing archives.
Wednesday, October 9, 2024 12:30 p.m.
AGENDA
SB 668 Sen. Hertel Health occupations; physical therapists; prescription requirement for physical therapy treatment; eliminate, and make other modifications to the practice of physical therapy.
SB 915 Sen. Hertel Mental health; hospitalization; person requiring treatment; revise, and modify certain procedures for treatment.
SB 916 Sen. Santana Criminal procedure; mental capacity; outpatient treatment for misdemeanor offenders with mental health issues; provide for.
SB 917 Sen. Irwin Mental health; other; hospital evaluations for assisted outpatient treatment; expand.
SB 918 Sen. Wojno Mental health; other; petition for access to assisted outpatient treatment; expand to additional health providers.
And any other business properly before the committee.
According to the Michigan Legislature, Senate Bill 668 passed in the Senate on 10/23 and is moving to the House of Representatives.
https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0668
This Bill, as well as legally defining the entity of a physical therapist or a physical therapist assistant, alters the wording of legislation regarding the practice of physical therapy to to be focused upon referrals as opposed to prescriptions.
As opposed to a physical therapist receiving a prescription from another health care professional requesting physical therapy for their patient, the legislation now states that they receive referrals. This referral focused language is supposed to place more volition on the part of the physical therapist. According to the bill summary, it is increasing the scope of practice of the physical therapist to, "include examining, evaluating, and testing an individual with a mechanical, physiological, or developmental impairment, a functional limitation, or a disability or other health movement-related condition to determine the cause of the physical therapy problem to be treated."
What should be considered very carefully is how this will effect the amount of paperwork that a physical therapist has to complete on a given day. My mother is a physical therapist, and I too often can think of times where she comes home after a 12 hour day only to complete several more hours of paperwork referred to colloquially among the therapists as "evals". Evaluations of new patients and entering them into the extensive online hospital system is time consuming and draining. We should think extensively about the possible effects of possibly adding more onto the plate of these therapists, especially during the patient referral or evaluation process.
(1) If a physical therapist who is treating a patient upon on the receipt of a referral from a health care professional, as described in section 17820 the physical therapist shall do all of the following, as applicable:
(a) Refer the patient back to the health care professional who made the referral for treatment if the physical therapist has reasonable cause to believe that symptoms or conditions are present that require services beyond the scope of practice of physical therapy.
(b) Consult with the health care professional who made the referral for treatment if the patient does not show reasonable response to treatment in a time period consistent with the standards of practice as determined by the board.(2) If a physical therapist who is treating a patient without a referral from a health care professional, under the conditions authorized in section 17820, the physical therapist shall do all of the following, as applicable:
(a) Refer the patient to an appropriate health care professional for treatment if the physical therapist has reasonable cause to believe that symptoms or conditions are present that require services beyond the scope of practice of physical therapy.
(b) Consult with an appropriate health care professional if the patient does not show reasonable response to treatment in a time period consistent with the standards of practice as determined by the board.
https://www.legislature.mi.gov/documents/2023-2024/billengrossed/Senate/pdf/2023-SEBS-0668.pdf
MDHHS's Assisted Outpatient Treatment (AOT) is a court-ordered program for individuals suffering from serious mental illness to participate in outpatient mental health treatment for a period of time. This program is intended to help people cope with their illness before it progresses to the point of hospitalization or incarceration. It is a court ordered program because these individuals may not willingly participate in various therapies. These court ordered therapies can include a variety of mandatory treatments, from therapy or case management to medication.
Michigan Senate Bills 915, 916, 917 and 918 all make amendments to this AOT program in a variety of ways:
https://legislature.mi.gov/documents/2023-2024/billanalysis/Senate/pdf/2023-SFA-0915-F.pdf
Senate Bill 915 (S-1) would amend Chapter 4 (Civil Admission and Discharge Procedures: Mental Illness) of the Mental Health Code to do the following:
-- Require a patient to be referred to a community mental health services program if a psychiatrist certified that the patient required assisted outpatient treatment (AOT).
-- Modify the type of health professional that could testify to a patient's need for AOT.
-- Modify the duration of second and third consecutive court orders for involuntary mental health treatment.
-- Allow a court, without a hearing, to convene a conference with an individual who was out of compliance with a court order for AOT and the individual's supervising agency to review compliance with the order.
-- Allow a peace officer to take an individual into protective custody for examination for mental health intervention if the officer had reasonable cause to believe the individual required treatment, instead of if the officer observed conduct that caused the officer to believe such.Senate Bill 916 (S-1) would amend the Mental Health Code to do the following:
-- Allow a physician, psychologist, or qualified health professional who had personally examined an individual to testify that that individual needed AOT.
-- Allow a prosecuting attorney, defendant, or defense counsel to bring a motion for an assessment to determine if a defendant met the criteria for misdemeanor diversion to AOT at the time a misdemeanor was charged, or any later time before trial.
-- Require a petition for diversion to AOT to be dismissed upon objection by a prosecuting attorney or defendant.
-- Allow a court to enter an order for diversion to AOT for up to 180 days.
-- Allow a court to modify a diversion to AOT, such as by diverting to inpatient hospitalization, if a defendant failed to comply with the AOT.
-- Require misdemeanor charges to remain pending upon diversion to AOT and to be dismissed as a condition of release from AOT.Senate Bill 917 (S-1) would amend the Mental Health Code to allow an individual who filed a petition asserting that another individual required mental health treatment to request and access mediation to resolve a dispute between the individual requiring treatment and the appropriate community mental health services program related to planning and providing services or support to the individual requiring treatment. In addition, if an individual were required by a court order to receive mental health services due to a petition, the bill would require a hospital to detain that individual for up to 24 hours.
Senate Bill 918 (S-1) would amend the Mental Health Code to allow a hospital director, agency, physician, psychologist, qualified mental health professional, or individual to file a petition for a second or continuing order of involuntary mental health treatment at least 14 days before the expiration of a current order of AOT if the individual receiving treatment were likely to refuse voluntary treatment and needed continued treatment.
The two bills which may prove problematic over time are bills 915 and 918. As SB915 reads on page 11, "If it comes to the attention of the court that an individual subject...is not complying with the order, that the assisted outpatient treatment has not been or will not be sufficient to prevent harm to the individual or to others, or that the individual believes that the assisted outpatient treatment program is not appropriate, the court may...without hearing...modify the order."
The court is able to relax the charge to outpatient therapy or heighten the charge to hospitalization at will, seemingly with any indication they may find. Having a more distinct communication system that requires a healthcare professional as a mediator between the courts and the patient may prove more robust in the long run.
SB918 is a short bill regarding who can file for the reapplication process of an unwilling person to this program. I found the wording a bit too broad. As the bill states on page 2, "a hospital director, an agency, a mental health professional supervising an individual's assisted outpatient treatment, or an individual 18 years of age or older may file a petition for a second or continuing order of involuntary mental health treatment if the individual continues to be a person requiring treatment and the individual is likely to refuse treatment on a voluntary basis when the order expires."
The inclusion of the word "agency" is particularly what I dislike about the bill. If a patient is in need of help and unwilling to participate in treatment, the request should come from a healthcare professional who cared for them or from a personal friend or family member who has their best interests in mind. When legislation like this decides who and who does not receive mandatory hospitalizations without hearing, agencies seem a bit too impersonal for that process.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























